Funding allows Stem Cell to finish merger with South Korean firm

03/17/2009 | American City Business Journals

Stem Cell Therapy International said it has secured short-term funding to finalize its merger with HistoStem, a South Korean firm that manages a cord blood and stem cell bank, to create a firm called AmStem International. Under the merger, AmStem is expected to bring to the U.S. adult stem cells from Asia for use in clinical studies and treatments.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA